Significant Transformation at Soleo Health
H.I.G. Capital, a well-respected global investment firm, recently completed the sale of its portfolio company, Soleo Health, to funds managed by Court Square Capital and WindRose Health Investors. This strategic move is anticipated to propel Soleo to new heights within the healthcare industry, especially as it continues to specialize in delivering complex infusion therapies for patients with unique medical challenges.
Understanding Soleo Health's Operations
Soleo Health operates a comprehensive, diversified infusion platform aimed at providing personalized healthcare services. This platform is instrumental in supporting patients with complex, rare, and ultra-rare medical conditions, ensuring they receive the necessary care in a timely manner. Soleo manages 26 pharmacies and has over 30 ambulatory infusion suites, providing services nationwide.
The Role of H.I.G. Capital in Soleo's Growth
During H.I.G. Capital's tenure, they played a vital role in transforming Soleo into a leader in the specialty pharmacy and infusion business. This involved expanding its footprint through the establishment of new pharmacies and infusion suites, introducing innovative clinical models, and diversifying payor options and therapy offerings. Investments in talent and infrastructure were also prioritized to enhance operational efficiency and care quality.
Leadership's Recognition of H.I.G.'s Support
Drew Walk, President and CEO of Soleo Health, highlighted H.I.G.'s exceptional partnership in their journey to becoming a market leader. He noted that H.I.G.'s strategic support significantly bolstered their capabilities, enabling Soleo to extend exceptional care to a broader patient base.
A Bright Future Ahead for Soleo Health
Scott Zhu, Managing Director at H.I.G., expressed his admiration for Soleo's transformation from a regional player to a nationally recognized specialty care provider. The focus now lies on exploring various growth opportunities available to Soleo, paving the way for advancements in the infusion therapy sector.
About Soleo Health
Soleo Health stands as a national independent provider of complex specialty pharmacy services, offering infusion therapy in home settings and alternate care sites. Their interdisciplinary team consists of highly qualified clinical pharmacists, registered nurses, and patient care specialists who work collaboratively with referring medical professionals to optimize patient care and enhance overall service delivery. Soleo’s commitment to quality is reflected in its numerous accreditations, including recognition for excellence in rare diseases and orphan drugs.
About H.I.G. Capital
H.I.G. Capital is a prominent global alternative investment firm managing approximately $67 billion in capital. With a vast network of offices in major cities, it focuses on providing both debt and equity capital to middle-market enterprises. H.I.G. Capital is well-known for its operationally focused approach, thereby successfully guiding investments in various industries.
Frequently Asked Questions
What led to the sale of Soleo Health?
The sale is part of a strategic initiative to enhance Soleo Health's growth prospects under new management while transitioning H.I.G. Capital to focus on new investment opportunities.
What is Soleo Health's primary service offering?
Soleo Health specializes in complex specialty pharmacy services and infusion therapy, catering specifically to patients with rare and ultra-rare conditions.
How many locations does Soleo Health operate?
Soleo Health operates 26 pharmacies and over 30 ambulatory infusion suites across the nation.
Who are the new investors in Soleo Health?
The company has been sold to funds managed by Court Square Capital and WindRose Health Investors.
What support did H.I.G. Capital provide to Soleo Health?
H.I.G. Capital significantly supported Soleo through investment in talent and infrastructure, as well as strategic expansions that have evolved the company into a market leader.
